Peripheral Vascular Device Market Insights Webinar

Monday, June 2, 2008 General News J E 4
Millennium Research Group presents a complimentary Webinar outlining ourknowledge of the peripheral vascular (PV) device industry. Sign up to gaininformation derived from our Global Peripheral Vascular Device report seriesand PV Marketrack(TM).

In this one-hour presentation, our Analyst will discuss numerous PV devicemarket dynamics, including the following:

A question and answer session will follow the presentation.

To enroll for this event, please use the Internet URL below to reach ourWebEx page and then click the "Register" button at the bottom of the page.Once you complete the brief registration form, click "Submit".

If you have any questions concerning your registration, please contactShiu-Yik Au at 416-364-7776 ext. 123 or at

About Millennium Research Group

Millennium Research Group (, a Decision Resources, (, is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.

All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.WALTHAM, Mass., June 2 /PRNewswire/ -- WHAT: PERIPHERAL VASCULAR DEVICE MARKET INSIGHTS WEBINAR (audio and online presentation) WHEN: Thursday, June 5, 2008, 11 am US Eastern Time, 5 pm Central European Time (Paris) PRESENTER: Stephanie LaBelle, Analyst from Millennium Research Group TO ENROLL: Please use the link below to register or call Shiu-Yik Au at 416-364-7776 ext. 123

SOURCE Millennium Research Group


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Up for Debate This Week: Funds for 'Green' Schools...
New Nexavar Data Presented in Multiple Tumor Types...